Veradermics Inc
NYSE:MANE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Veradermics Inc
NYSE:MANE
|
US |
|
Gecina SA
LSE:0OPE
|
FR |
|
S
|
Stellantis NV
XMUN:8TI
|
NL |
|
Svenska Cellulosa SCA AB
F:SCA
|
SE |
|
F
|
Firstcash Holdings Inc
F:FF6
|
US |
|
Meta Platforms Inc
MIL:1FB
|
US |
|
U
|
United Overseas Bank Ltd
OTC:UOVEF
|
SG |
|
Klaveness Combination Carriers ASA
F:36K
|
NO |
|
Aeon Co Ltd
F:JUS1
|
JP |
|
V
|
Vital Healthcare Property Trust
OTC:VTHPF
|
NZ |
|
Thule Group AB
F:TU0
|
SE |
|
B
|
Banpu Power PCL
SET:BPP
|
TH |
|
F
|
Frontier Lithium Inc
SWB:HL2
|
CA |
|
T
|
Toyota Motor Corp
XBER:TOM
|
JP |
|
Biogaia AB
OTC:BGLAF
|
SE |
|
Eiffage SA
PAR:FGR
|
FR |
Wall St Price Targets
MANE Price Targets Summary
Veradermics Inc
According to Wall Street analysts, the average 1-year price target for MANE is 134.9 USD with a low forecast of 121.2 USD and a high forecast of 144.9 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MANE's stock price target?
Price Target
134.9
USD
According to Wall Street analysts, the average 1-year price target for MANE is 134.9 USD with a low forecast of 121.2 USD and a high forecast of 144.9 USD.